won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. For more detailed information about the cookies we use, please see our
under other service revenues and device sales. As the acquisition value was higher than CSL’s net identifiable assets, AIS recognized the value difference as goodwill amounting to Bt2.8bn. With the
strategy is the key tool for this industry. According to performance loss and franchise model concept, it affects with significant drop of the business valuation of the subsidiary company. In 2017, the
the key tool for this industry. According to performance loss and franchise model concept, it affects with significant drop of the business valuation of the subsidiary company. In 2017, the Company has
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the